Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Quanterix Corporation

    NASDAQ: QTRX · Real-Time Price · USD
    5.29
    -0.22 (-3.99%)
    At close: May 09, 2025, 3:59 PM
    5.41
    2.27%
    After-hours: May 09, 2025, 04:34 PM EDT
    -3.99%
    Bid 5.15
    Market Cap 205.36M
    Revenue (ttm) 137.02M
    Net Income (ttm) -39.53M
    EPS (ttm) -1
    PE Ratio (ttm) -5.29
    Forward PE -5.32
    Analyst Buy
    Ask 6.6
    Volume 298,319
    Avg. Volume (20D) 743,945
    Open 5.60
    Previous Close 5.51
    Day's Range 5.28 - 5.59
    52-Week Range 4.67 - 19.18
    Beta 1.11

    About QTRX

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol QTRX
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for QTRX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Next Earnings Release

    Quanterix Corporation is scheduled to release its earnings on May 12, 2025, during market hours.
    Analysts project revenue of ... Unlock content with Pro Subscription

    Why Price Moved

    Why Price Moved is a one-sentence explanation of why a stock is moving higher or down. By removing noise and collecting signals from news, press releases and SEC filings, we can pinpoint the trigger for price movements.
    1 month ago
    -1.79%
    Quanterix Corporation shares are trading lower aft... Unlock content with Pro Subscription
    5 months ago
    -18.26%
    Quanterix shares are trading lower. The company reported Q3 financial results.
    news image

    3 days ago · businesswire.com

    AKOYA BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akoya Biosciences, Inc. - AKYA

    NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Akoya Bioscience...

    news image

    4 days ago · businesswire.com

    Quanterix To Report First Quarter 2025 Financial Results on May 12, 2025

    BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that it will host a conferen...

    news image

    1 week ago · businesswire.com

    Quanterix and Akoya Biosciences Announce Amended Merger Agreement

    BILLERICA, Mass. & MARLBOROUGH, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection, and Akoya Biosciences ...

    news image

    3 weeks ago · businesswire.com

    Kent Lake Files Definitive Proxy Statement and Sends Letter to Quanterix Shareholders

    RINCON, Puerto Rico--(BUSINESS WIRE)--Kent Lake PR LLC (“Kent Lake”), a holder of approximately 7.7% of the outstanding common stock of Quanterix Corporation (“Quanterix” or the “Company”) (NASDAQ: QT...

    news image

    3 weeks ago · businesswire.com

    Tikvah Management Calls on Quanterix to Explain the Egregious Terms of Convertible Notes Purchased from Akoya Biosciences

    CHARLOTTE, N.C.--(BUSINESS WIRE)--Tikvah Management LLC (together with its affiliates, “Tikvah” or “we”), which owns approximately 1.5% of the outstanding common shares of Quanterix Corp. (“Quanterix”...

    news image

    1 month ago · businesswire.com

    Kent Lake Comments on Quanterix's Value Destructive Bridge Financing for Financially Troubled Akoya

    RINCON, Puerto Rico--(BUSINESS WIRE)--Kent Lake PR LLC (“Kent Lake”) is a holder of approximately 7.5% of the outstanding common stock of Quanterix Corporation (“Quanterix” or the “Company”) (NASDAQ: ...

    news image

    1 month ago · businesswire.com

    Quanterix Showcases Innovation Powered by Simoa® at AD/PD with Customer Research and New Dried Blood Spot Extraction Kit

    BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced the inclusion of a new dried...

    news image

    1 month ago · businesswire.com

    Tikvah Management Announces Intention to Vote AGAINST Quanterix's Proposed Merger with Akoya Biosciences

    CHARLOTTE, N.C.--(BUSINESS WIRE)--Tikvah Management LLC (together with its affiliates, “Tikvah” or “we”), which owns approximately 1.5% of the outstanding common shares of Quanterix Corp. (Nasdaq: QTR...

    news image

    1 month ago · seekingalpha.com

    Quanterix Corporation (QTRX) Q4 2024 Earnings Call Transcript

    Quanterix Corporation (NASDAQ:QTRX ) Q4 2024 Earnings Conference Call March 17, 2025 4:30 PM ET Company Participants Joshua Young - Head of IR Masoud Toloue - President and CEO Vandana Sriram - CFO Co...

    news image

    1 month ago · businesswire.com

    Quanterix Releases Financial Results for the Fourth Quarter of 2024

    BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection, today announced financial results for the f...

    Add to Watchlist